Mount Sinai Genomics, INC. (D/B/A Sema4)
enables physicians & consumers to engage the digital universe of health data.
Based in CT
🤖
AI Overview
With $100K in lobbying spend across 6 quarterly filings, Mount Sinai Genomics, INC. (D/B/A Sema4) is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2019.
$100K
Total Spend
2
Years Active
1
Firms Hired
3
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $80K |
| 2019 | $20K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
- •newborn screening, reimbursement of diagnostics
- •companion diagnostics at FDA, no bill # Verifying Accurate Leading-Edge IVCT Development (VALID) Act, coverage and reimbursement of molecular diagnostics.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.